my account
Login
  Loading... Please wait...

Product Details

Cilostazol | PDE3A inhibitor

Cilostazol (73963-72-1) is a clinically approved phosphodiesterase III (PDE3) inhibitor (IC50 = 0.2 μM) and anti-thrombotic agent. It inhibits platelet aggregation and is a direct arterial vasodilator.

References/Citations
1) Schror (2002) The pharmacology of cilostazol; Diabetes Obes. Metab., 4 S14

swipe
Focus Biomolecules cell signaling reagent supplier, chemical structure of Cilostazol | PDE3A inhibitor | CAS 73963-72-1

Catalog#  10-1131

$60.00
Quantity
Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee.
 
Request Bulk Quote
CAS:
73963-72-1
Catalog Number:
10-1131
Activity:
PDE3A inhibitor
Chemical Name:
6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1H)-quinolinone
Molecular Weight:
369.46
Molecular Formula:
C20H27N5O2
Solubility:
Soluble in DMSO (up to 20 mg/ml).
Physical Properties:
White solid
Purity:
98% by TLC
NMR (Conforms)
Storage Temperature:
RT
Stability:
Stable for 2 years as supplied. Solutions in DMSO may be stored at -20°C for up to 2 months
Shipping Code:
RT
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications.

Focus BiomoleculesPlymouth Meeting, PA USA1-855-FOCUS21

Connect with Focus

Click the button below to add the Cilostazol | PDE3A inhibitor to your wish list.